Suvretta Capital Management, Llc - Sep 30, 2025 SCHEDULE 13G/A Report for Palvella Therapeutics, Inc. Common stock, $0.001 par value per share (PVLA)

Filing Manager: SUVRETTA CAPITAL MANAGEMENT, LLC
Reporting Manager: SUVRETTA CAPITAL MANAGEMENT, LLC
Security: Palvella Therapeutics, Inc. Common stock, $0.001 par value per share
Symbol: PVLA
Shares outstanding: 11.1M shares
Disclosed Ownership: 822K shares
Ownership: 7.4%
Form type: SCHEDULE 13G/A
Date filed: 11/13/2025, 05:31 PM
Date of event: Sep 30, 2025
Previous filing: Dec 20, 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
SUVRETTA CAPITAL MANAGEMENT, LLC	7.4%	822K	822K	By: /s/ Andrew Nathanson	Andrew Nathanson, General Counsel and Chief Compliance Officer
AVERILL MASTER FUND, LTD.	6.5%	714K	714K	By: /s/ Andrew Nathanson	Andrew Nathanson, Authorized Signatory
AARON COWEN	7.4%	822K	822K	By: /s/ Aaron Cowen	Aaron Cowen